
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
FucT-l CRISPR/Cas9 KO Plasmid (m) | sc-420423 | 20 µg | $397.00 |
Fut1 encodes α(1,2)fucosyltransferase 1 (FucT-1), a Golgi-resident glycosyltransferase that transfers fucose from GDP-fucose to terminal galactose residues, generating α1,2-fucosylated glycans such as H-type antigens on glycoproteins and glycolipids. This enzymatic step is a core component of glycosphingolipid and glycoprotein maturation and shapes cell-surface carbohydrate patterns that influence lectin binding, membrane organization, and intercellular recognition. Fut1-dependent fucosylation intersects with pathways controlling epithelial differentiation, mucosal barrier function, and host–microbe interactions through modulation of glycan-mediated adhesion and signaling. Altered α1,2-fucosylation has been associated with inflammation and immune dysregulation in multiple contexts, making Fut1 a useful node for mechanistic studies of glycan-dependent phenotypes.
FucT-l CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Fut1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Fut1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Fut1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish FucT-l protein expression.
This CRISPR knockout system enables efficient generation of Fut1-deficient cell models for investigation of FucT-l signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.